 |
|
|
| |
NYS Durb Final Report - Sept 15 2016 Meeting
|
| |
| |
Download the PDF here
Please note that the below changes go into effect on November 17, 2016 and only apply to FFS Medicaid.
Attached is the final summary report from the September meeting of the NYS Drug Utilization Review Board. The hepatitis C summary can be found on page 4.
⋅ Epclusa(GT 2 and 3) has been added to the preferred list
⋅ Viekira XR has been added to the preferred list
The summary report is also available at:
https://www.health.ny.gov/health_care/medicaid/program/dur/meetings/2016/09/summary_durb.pdf
Colleen Flanigan, RN, MS
Director, Bureau of Hepatitis Health Care
New York State Department of Health
AIDS Institute
Empire State Plaza, Corning Tower - 429
Albany, NY 12237
(o) 518-486-6806
(f) 518-474-2749
Email: colleen.flanigan@health.ny.gov
|
| |
|
|
|
|
|
